Metraipolis › archive › dc_bf80666be407

Prognostic Significance of baseline systemic inflammation markers in PD-L1-negative advanced non-small cell lung cancer patients treated with the BRICS… — Europe PMC PMID:41451214

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41451214
DOI
10.3389/fimmu.2025.1686521
License (as archived)
solo-consultazione
Archived
2026-11-07T17:54:02.287Z
SHA-256 of the archived text
3516cfb6e1b24620c7256d86b7a2dac1a3919f3021f42e075dab81840eebafd4
Stable URL of this page
https://metraipolis.com/documento/dc_bf80666be407

How to cite

Prognostic Significance of baseline systemic inflammation markers in PD-L1-negative advanced non-small cell lung cancer patients treated with the BRICS… — Europe PMC PMID:41451214 — Europe PMC (en), https://europepmc.org/article/MED/41451214 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bf80666be407 (Metraipolis archive dc_bf80666be407, sha256 3516cfb6e1b24620c7256d86b7a2dac1a3919f3021f42e075dab81840eebafd4)
BibTeX
@misc{dcbf80666be407,
  title = {Prognostic Significance of baseline systemic inflammation markers in PD-L1-negative advanced non-small cell lung cancer patients treated with the BRICS… — Europe PMC PMID:41451214},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41451214},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bf80666be407; sha256 3516cfb6e1b24620c7256d86b7a2dac1a3919f3021f42e075dab81840eebafd4},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41451214. Agents can read the archived copy with the MCP tool read_document.